Brain Seminar Series: "The central serotonin2B receptor & dopamine ascending pathways: new opportunities for treating schizophrenia"
The Brain Repair and Integrative Neuroscience Program of the RI-MUHC is pleased to announce their next presentation:
"The central serotonin2B receptor & dopamine ascending pathways: new opportunities for treating schizophrenia"
By Dr. Umberto Spampinato (University of Bordeaux)
Via Zoom 鈥� Registration is free, but mandatory
Dr. Umberto Spampinato Biosketch
Dr Spampinato is currently Professor of Neuropharmacology at the University of Bordeaux, in France where he heads the 鈥淣europharmacology and Functional Neurochemistry鈥� Research Group, in the INSERM Unit 1215, and is also associate consultant in the Neurology Department for Parkinson's disease and movement disorders, and in the Genetic Department for Huntington鈥檚 disease. His academic education was paralleled by extensive preclinical and clinical research training, which started in 1974 in Italy, and continued in different well-renowned neurochemistry and neuropharmacology laboratories and neurology departments in Italy and France until his own research group was established in the University of Bordeaux 2 in 1991. Throughout his career, Dr Spampinato's research has focused on the functional role of serotonin in the basal ganglia, with particular attention to the serotonin-dopamine interaction and its relevance for the mechanisms of action of psychotropic drugs, the neurobiological bases of extrapyramidal disorders and drug addiction. He is also actively involved in clinical studies on Parkinson's disease, Huntington鈥檚 disease and participates in the evaluation of new pharmacological treatments for these disorders. Dr Spampinato has published numerous scientific articles and book chapters and he regularly serves as a reviewer for numerous scientific journals.
